Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial

Published:2014-09-08 Issue:11 Volume:21 Page:762-768
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Omata Masao¹,Nishiguchi Shuhei²,Ueno Yoshiyuki³,Mochizuki Hitoshi¹,Izumi Namiki⁴,Ikeda Fusao⁵,Toyoda Hidenori⁶,Yokosuka Osamu⁷,Nirei Kazushige⁸,Genda Takuya⁹,Umemura Takeji¹⁰,Takehara Tetsuo¹¹,Sakamoto Naoya¹²,Nishigaki Yoichi¹³,Nakane Kunio¹⁴,Toda Nobuo¹⁵,Ide Tatsuya¹⁶,Yanase Mikio¹⁷,Hino Keisuke¹⁸,Gao Bing¹⁹,Garrison Kimberly L.¹⁹,Dvory‐Sobol Hadas¹⁹,Ishizaki Akinobu¹⁹,Omote Masa¹⁹,Brainard Diana¹⁹,Knox Steven¹⁹,Symonds William T.¹⁹,McHutchison John G.¹⁹,Yatsuhashi Hiroshi²⁰,Mizokami Masashi¹⁷

Affiliation:

1. Yamanashi Prefectural Hospital Organization Yamanashi Japan

2. Hyogo College of Medicine Hyogo Japan

3. Yamagata University Yamagata Japan

4. Musashino Red Cross Hospital Tokyo Japan

5. Okayama University Okayama Japan

6. Ogaki Municipal Hospital Gifu Japan

7. Chiba University Chiba Japan

8. Nihon University Tokyo Japan

9. Juntendo University Tokyo Japan

10. Shinshu University Nagano Japan

11. Osaka University Osaka Japan

12. Hokkaido University Hokkaido Japan

13. Gifu Municipal Hospital Gifu Japan

14. Akita City Hospital Akita Japan

15. Mitsui Memorial Hospital Tokyo Japan

16. Kurume University Kurume Japan

17. National Center for Global Health and Medicine Tokyo Japan

18. Kawasaki Medical School Okayama Japan

19. Gilead Sciences, Inc. Foster City CA USA

20. National Hospital Organization Nagasaki Medical Center Nagasaki Japan

Funder

Gilead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.12312

Reference14 articles.

1. Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan

2. Sex- and Age-Specific Carriers of Hepatitis B and C Viruses in Japan Estimated by the Prevalence in the 3,485,648 First-Time Blood Donors during 1995–2000

3. Spread Times of Hepatitis C Virus Estimated by the Molecular Clock Differ among Japan, the United States and Egypt in Reflection of Their Distinct Socioeconomic Backgrounds

4. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression

5. Changes in hepatitis C virus genotype distribution in Japan

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors;Scientific Reports;2024-07-16

2. Liver biopsy in the post-hepatitis C virus era in Japan;World Journal of Gastroenterology;2024-04-14

3. Direct‑acting antiviral treatment is safe and effective for chronic HCV patients with psychiatric disorders;Experimental and Therapeutic Medicine;2023-07-07

4. Efficacy and safety of direct-acting antiviral regimen for patients with hepatitis C virus genotype 2: A systematic review and meta-analysis;2023-03-31

5. The incidence of all organ malignancies and overall survival of patient with sustained virological response of HCV-comparable to SMR (standardized mortality ratio) of Japan general population;Hepatology International;2023-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3